These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2729341)

  • 1. Zidovudine-associated myopathy.
    Gertner E; Thurn JR; Williams DN; Simpson M; Balfour HH; Rhame F; Henry K
    Am J Med; 1989 Jun; 86(6 Pt 2):814-8. PubMed ID: 2729341
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of myopathy in a placebo-controlled zidovudine trial.
    Simpson DM; Slasor P; Dafni U; Berger J; Fischl MA; Hall C
    Muscle Nerve; 1997 Mar; 20(3):382-5. PubMed ID: 9052824
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuromuscular complications of human immunodeficiency virus infection and antiretroviral therapy.
    Miller RG
    West J Med; 1994 May; 160(5):447-52. PubMed ID: 8048229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of cytomegalovirus retinitis in persons with AIDS with high-dose intravenous acyclovir.
    Sha BE; Benson CA; Deutsch TA; Urbanski PA; Phair JP; Kessler HA
    J Infect Dis; 1991 Oct; 164(4):777-80. PubMed ID: 1654361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zidovudine therapy of asymptomatic HIV1-infected patients and combined zidovudine-acyclovir therapy of HIV1-infected patients with oral hairy leukoplakia.
    Brockmeyer NH; Kreuzfelder E; Mertins L; Daecke C; Goos M
    J Invest Dermatol; 1989 Apr; 92(4):647. PubMed ID: 2703729
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapy for HIV-1-related nephritis with zidovudine.
    Harrer T; Hunzelmann N; Stoll R; Baur A; Kalden JR
    AIDS; 1990 Aug; 4(8):815-7. PubMed ID: 2261137
    [No Abstract]   [Full Text] [Related]  

  • 7. AIDS treatment. Confusion over therapy.
    Aldhous P
    Nature; 1992 Jan; 355(6356):102. PubMed ID: 1729639
    [No Abstract]   [Full Text] [Related]  

  • 8. Mitochondrial myopathy associated with chronic zidovudine therapy in AIDS.
    Peters BS; Winer J; Landon DN; Stotter A; Pinching AJ
    Q J Med; 1993 Jan; 86(1):5-15. PubMed ID: 8438050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association between acyclovir use and survival in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group.
    Gallant JE; Moore RD; Keruly J; Richman DD; Chaisson RE
    J Infect Dis; 1995 Aug; 172(2):346-52. PubMed ID: 7622876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exacerbation of HIV-associated myopathy by zidovudine.
    Berger JR; Shebert R; Gregorios JB
    AIDS; 1991 Feb; 5(2):229-30. PubMed ID: 2031699
    [No Abstract]   [Full Text] [Related]  

  • 11. Myelopathy as a presenting sign of acquired immunodeficiency syndrome.
    Fiser RT; Hickerson SL; Sharp GB; Schutze GE
    Pediatr Infect Dis J; 1995 Sep; 14(9):808-9. PubMed ID: 8559634
    [No Abstract]   [Full Text] [Related]  

  • 12. Mitochondrial myopathy caused by long-term zidovudine therapy.
    Dalakas MC; Illa I; Pezeshkpour GH; Laukaitis JP; Cohen B; Griffin JL
    N Engl J Med; 1990 Apr; 322(16):1098-105. PubMed ID: 2320079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS).
    Krown SE; Gold JW; Niedzwiecki D; Bundow D; Flomenberg N; Gansbacher B; Brew BJ
    Ann Intern Med; 1990 Jun; 112(11):812-21. PubMed ID: 1971504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of sequential therapy with zidovudine plus acyclovir, dideoxyinosine, and dideoxycytidine in patients with severe human immunodeficiency virus infection.
    Nguyen BY; Shay LE; Wyvill KM; Pluda JM; Brawley O; Cohen RB; Whitcup SM; Venzon DJ; Broder S; Yarchoan R
    J Infect Dis; 1993 Oct; 168(4):810-7. PubMed ID: 8397267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex with a regimen of 3'-azido-2',3'-dideoxythymidine (azidothymidine or zidovudine) and acyclovir. A pilot study.
    Surbone A; Yarchoan R; McAtee N; Blum MR; Maha M; Allain JP; Thomas RV; Mitsuya H; Lehrman SN; Leuther M
    Ann Intern Med; 1988 Apr; 108(4):534-40. PubMed ID: 2964805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acyclovir improves survival.
    AIDS Patient Care; 1994 Jun; 8(3):165. PubMed ID: 11362142
    [No Abstract]   [Full Text] [Related]  

  • 17. Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished?
    Simpson DM; Citak KA; Godfrey E; Godbold J; Wolfe DE
    Neurology; 1993 May; 43(5):971-6. PubMed ID: 8492955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Criteria for use of zidovudine in adult and pediatric inpatients and outpatients.
    Goodwin SD; Shipp KW
    Clin Pharm; 1992 Jan; 11(1):63-8. PubMed ID: 1730181
    [No Abstract]   [Full Text] [Related]  

  • 19. From the Food and Drug Administration.
    Nightingale SC
    JAMA; 1989 Aug; 262(6):740. PubMed ID: 2545935
    [No Abstract]   [Full Text] [Related]  

  • 20. Myopathy in human immunodeficiency virus-infected children receiving long-term zidovudine therapy.
    Walter EB; Drucker RP; McKinney RE; Wilfert CM
    J Pediatr; 1991 Jul; 119(1 Pt 1):152-5. PubMed ID: 1906098
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.